Found: 11
Select item for more details and to access through your institution.
Front & Back Matter.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 5, p. 1, doi. 10.1159/000542187
- Publication type:
- Article
Nivolumab plus Ipilimumab: A Novel First-Line Combination Immunotherapy for Unresectable Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 5, p. 459, doi. 10.1159/000540801
- By:
- Publication type:
- Article
Erratum.
- Published in:
- 2024
- Publication type:
- Correction Notice
Risk of Hepatocellular Carcinoma by Steatotic Liver Disease and Its Newly Proposed Subclassification.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 5, p. 561, doi. 10.1159/000538301
- By:
- Publication type:
- Article
Prognostic Value of Pathological Response for Patients with Unresectable Hepatocellular Carcinoma Undergoing Conversion Surgery.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 5, p. 498, doi. 10.1159/000536376
- By:
- Publication type:
- Article
Characterization of Tumor Responses in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib in the Phase 3 Randomized Trial: REFLECT.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 5, p. 537, doi. 10.1159/000537947
- By:
- Publication type:
- Article
Disease Etiology Impact on Outcomes of Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab: A Real-World, Multicenter Study.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 5, p. 522, doi. 10.1159/000537915
- By:
- Publication type:
- Article
Outcomes of Post-Immunotherapy Durable Responders of Advanced Hepatocellular Carcinoma– with Emphasis on Locoregional Therapy for Oligoprogression.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 5, p. 509, doi. 10.1159/000536549
- By:
- Publication type:
- Article
Tislelizumab versus Sorafenib in First-Line Treatment of Unresectable Hepatocellular Carcinoma: Impact on Health-Related Quality of Life in RATIONALE-301 Study.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 5, p. 548, doi. 10.1159/000537966
- By:
- Publication type:
- Article
Combination Assay of Methylated HOXA1 with Tumor Markers Shows High Sensitivity for Detection of Early-Stage Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 5, p. 487, doi. 10.1159/000536211
- By:
- Publication type:
- Article
Management Consensus Guidelines for Hepatocellular Carcinoma: 2023 Update on Surveillance, Diagnosis, Systemic Treatment, and Posttreatment Monitoring by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 5, p. 468, doi. 10.1159/000537686
- By:
- Publication type:
- Article